Comprehensive tumor profiling identifies numerous biomarkers of drug response in cancers of unknown primary site: analysis of 1806 cases.
Saved in:
| Title: | Comprehensive tumor profiling identifies numerous biomarkers of drug response in cancers of unknown primary site: analysis of 1806 cases. |
|---|---|
| Authors: | Gatalica Z; Caris Life Sciences, Phoenix, United States of America., Millis SZ; Caris Life Sciences, Phoenix, United States of America., Vranic S; Department of Pathology, Clinical Center, University of Sarajevo, Sarajevo, Bosnia and Herzegovina., Bender R; Caris Life Sciences, Phoenix, United States of America., Basu GD; Caris Life Sciences, Phoenix, United States of America., Voss A; Caris Life Sciences, Phoenix, United States of America., Von Hoff DD; Translational Genomic Research Institute and Virginia G Piper Cancer Center, Phoenix, United States of America. |
| Source: | Oncotarget [Oncotarget] 2014 Dec 15; Vol. 5 (23), pp. 12440-7. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1949-2553 |
|---|---|
| DOI: | 10.18632/oncotarget.2574 |
